Financials

  • Market Capitalization 1.85 B
  • Employee 99
  • Founded 2019
  • CEO N/A
  • Website www.tayshagtx.com
  • Headquarter Delaware, United States
  • FIGI BBG00TJXFDP1
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-16.21
Relación precio/flujo de caja
396.94

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
2018
NBTX
Nanobiotix S.A. - ADSs
40.64 USD-1.43%+1.27%+8.17%+390.23%1.97 B USD
2048
IMCR
Immunocore Holdings plc - American Depositary Shares
36.32 USD-0.82%-0.49%+7.46%+8.48%1.87 B USD
2052
VIR
Vir Biotechnology, Inc. - Common Stock
10.94 USD+1.02%+9.07%+25.17%+82.94%1.85 B USD
2068
RXRX
Recursion Pharmaceuticals, Inc. - Class A Common Stock
3.40 USD+1.80%+3.98%+12.21%-25.93%1.82 B USD

Noticias